Severe hypocalcemia due to lenalidomide.
Inserm U1059, Department of Rheumatology, Hôpital Nord, University Hospital, 42055 Saint-Etienne cedex, France.
Shuing
S
Kong
Inserm U1059, Department of Rheumatology, Hôpital Nord, University Hospital, 42055 Saint-Etienne cedex, France.
Philippe
P
Collet
Inserm U1059, Department of Rheumatology, Hôpital Nord, University Hospital, 42055 Saint-Etienne cedex, France.
Hubert
H
Marotte
Inserm U1059, Department of Rheumatology, Hôpital Nord, University Hospital, 42055 Saint-Etienne cedex, France. Electronic address: thierry.thomas@chu-st-etienne.fr.
Thierry
T
Thomas
D000368:Aged; D002118:Calcium / Q000097:blood*; D006801:Humans; D006996:Hypocalcemia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use; D000077269:Lenalidomide; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D012720:Severity of Illness Index; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide; D002118:Calcium
Hypocalcemia; Lenalidomide; Multiple myeloma; Osteoclast; Tetany